Shuhua Yi

24PUBLICATIONS
158CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Haematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 20, 2026
Continuous or fixed-duration BTK inhibitor treatment for WM.

|Jun 26, 2026
MYD88 variants in chronic lymphocytic leukemia exhibit distinct biological behaviors and prognostic implications.

|Mar 05, 2026
Proteogenomic features define subtypes of mantle cell lymphoma.

Yuting Yan, Weihao Chen, Xinzhou Ge

|Feb 27, 2026
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001).

Wenqiang Yan, Chenxing Du, Rui Lv

|Feb 11, 2026
Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia.

Hao Sun, Romanos Sklavenitis Pistofidis, Shirong Liu

|Dec 07, 2025
Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Jennifer A Woyach, Lugui Qiu, Sebastian Grosicki

Pageof 4

Frequent Collaborators

11 joint publications

Gang An

10 joint publications

Dehui Zou

8 joint publications

Lugui Qiu

7 joint publications

Yuting Yan